Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for RDEB-associated neuropathic pain and itch
NCT03928093Phase 3Completed
- Sponsor
- SickKids
- Start
- Aug 2019
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pregabalin in Recessive Dystrophic Epidermolysis Bullosa (RDEB), sponsored by SickKids. Started Aug 2019; status: completed.
02
Drugs
pregabalin
03
Conditions
Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Beyond the preview
Go deeper on NCT03928093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03928093.